ASCO 2014 CLL News

Produced in association with
Exploring the Link Between Genetics and CLL Drug Resistance

Research is ongoing into the potential for patients to become resistant to new and emerging inhibitor CLL treatments. Dr. Richard Furman provides an update from ASCO 2014.

Published:

What Is ROR1?

Researchers are learning more about ROR1, an oncogene discovered on chronic lymphocytic leukemia (CLL) B cells.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on August 28, 2019